|
1
|
Hortobagyi GN, de la Garza Salazar J,
Pritchard K, Amadori D, et al: The global breast cancer burden:
variations in epidemiology and survival. Clin Breast Cancer.
6:391–401. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dowsett M and Dunbier AK: Emerging
biomarkers and new understanding of traditional markers in
personalized therapy for breast cancer. Clin Cancer Res.
14:8019–8026. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Alvarez JD, Yasui DH, Niida H, Joh T, Loh
DY and Kohwi-Shigematsu T: The MAR-binding protein SATB1
orchestrates temporal and spatial expression of multiple genes
during T-cell development. Genes Dev. 14:521–535. 2000.
|
|
4
|
Cai S, Han HJ and Kohwi-Shigematsu T:
Tissue-specific nuclear architecture and gene expression regulated
by SATB1. Nat Genet. 34:42–51. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dickinson LA, Joh T, Kohwi Y and
Kohwi-Shigematsu T: A tissue-specific MAR/SAR DNA-binding protein
with unusual binding site recognition. Cell. 70:631–645. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yasui D, Miyano M, Cai S, Varga-Weisz P
and Kohwi-Shigematsu T: SATB1 targets chromatin remodelling
to regulate genes over long distances. Nature. 419:641–645. 2002.
View Article : Google Scholar
|
|
7
|
Nie H, Maika SD, Tucker PW and Gottlieb
PD: A role for SATB1, a nuclear matrix association
region-binding protein, in the development of CD8SP thymocytes and
peripheral T lymphocytes. J Immunol. 174:4745–4752. 2005.
|
|
8
|
Agrelo R, Souabni A, Novatchkova M,
Haslinger C, Leeb M, Komnenovic V, Kishimoto H, Gresh L,
Kohwi-Shigematsu T, Kenner L and Wutz A: SATB1 defines the
developmental context for gene silencing by Xist in lymphoma and
embryonic cells. Dev Cell. 16:507–516. 2009. View Article : Google Scholar
|
|
9
|
Medema RH and Burgering BM: The X factor:
skewing X inactivation towards cancer. Cell. 129:1253–1254. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Han HJ, Russo J, Kohwi Y and
Kohwi-Shigematsu T: SATB1 reprogrammes gene expression to
promote breast tumour growth and metastasis. Nature. 452:187–193.
2008. View Article : Google Scholar
|
|
11
|
Gong F, Sun L, Wang Z, Shi J, Li W, Wang
S, Han X and Sun Y: The BCL2 gene is regulated by a special AT-rich
sequence binding protein 1- mediated long range chromosomal
interaction between the promoter and the distal element located
within the 3′-UTR. Nucleic Acids Res. 39:4640–4652. 2011.PubMed/NCBI
|
|
12
|
Yamayoshi A, Yashuhara M, Galande S,
Kobori A and Murakami A: Decoy-DNA against special AT-rich sequence
binding protein 1 inhibits the growth and invasive ability of human
breast cancer. Oligonucleotides. 21:115–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sobin LH and Wittekind Ch: TNM
Classification of Malignant Tumours. 6th edition. Wiley-Liss; New
York, NY: pp. 131–142. 2002
|
|
14
|
Ellis I: SSS-GXBGTFEV. Pathology and
Genetics of Tumours of the Breast and Female Genital Organs.
Tavassoéli FA and Devilee P: 5th edition. IARC Press; Lyon: pp.
13–59. 2003
|
|
15
|
Barrett JC, Fry B, Maller J and Daly MJ:
Haploview: analysis and visualization of LD and haplotype maps.
Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Patani N, Jiang W, Mansel R, Newbold R and
Mokbel K: The mRNA expression of SATB1 and SATB2 in human
breast cancer. Cancer Cell Int. 9:182009.
|
|
17
|
Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, Liu
XP and Xu ZD: Overexpression and involvement of special AT-rich
binding sequence protein 1 in multidrug resistance in human breast
carcinoma cells. Cancer Sci. 101:80–86. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanker LC, Karn T, Mavrova-Risteska L,
Ruckhäberle E, Gaetje R, Holtrich R, Kaufmann M, Rody A and
Wiegratz I: SATB1 gene expression and breast cancer
prognosis. Breast. 20:309–313. 2011. View Article : Google Scholar
|
|
19
|
Selinger CI, Cooper WA, Al-Sohaily S,
Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C and
Kohonen-Corish MR: Loss of special AT-rich binding protein 1
expression is a marker of poor survival in lung cancer. J Thorac
Oncol. 6:1179–1189. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun F, Lu X, Li H, Peng Z, Wu K, Wang G
and Tong Q: Special AT-rich sequence binding protein 1 regulates
the multidrug resistance and invasion of human gastric cancer
cells. Oncol Lett. 4:156–162. 2012.PubMed/NCBI
|
|
21
|
Chen H, Takahara M, Oba J, Xie L, Chiba T,
Takeuchi S, Tu Y, Nakahara T, Uchi H, Moroi Y and Furue M:
Clinicopathologic and prognostic significance of SATB1 in
cutaneous malignant melanoma. J Dermatol Sci. 64:39–44. 2011.
View Article : Google Scholar
|
